Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Dec-23 9:02 PM View:  | Park Sangwoo Director 10% Owner | Nkgen Biotech, Inc. (NKGN) | 13-Dec-23 | Gift | 2,500,000 | -- | -- | (19%) 13.02M to 10.52M | |
| 07-Dec-23 5:23 PM View: | Song Paul Y. Chief Executive Officer Director | Nkgen Biotech, Inc. (NKGN) | 07-Dec-23 | Purchase | 76 | $3.29 | $250.24 | < 1% 171.04K to 171.12K | |
| 07-Dec-23 5:23 PM View: | Song Paul Y. Chief Executive Officer Director | Nkgen Biotech, Inc. (NKGN) | 06-Dec-23 | Private Purchase | 75 | $3.32 | $250.00 | < 1% 170.97K to 171.04K | |
| 05-Dec-23 3:51 PM View: | Song Paul Y. Chief Executive Officer Director | Nkgen Biotech, Inc. (NKGN) | 05-Dec-23 | Purchase | 105 | $3.33 | $350.22 | < 1% 170.86K to 170.97K | |
| 05-Dec-23 3:51 PM View: | Song Paul Y. Chief Executive Officer Director | Nkgen Biotech, Inc. (NKGN) | 04-Dec-23 | Private Purchase | 163 | $3.07 | $499.73 | < 1% 170.7K to 170.86K | |
| 05-Dec-23 3:50 PM View: | Graf James A Interim CFO | Nkgen Biotech, Inc. (NKGN) | 04-Dec-23 | Purchase | 450 | $3.19 | $1,435.50 | < 1% 2.44M to 2.44M | |
| 05-Dec-23 3:50 PM View: | Graf James A Interim CFO | Nkgen Biotech, Inc. (NKGN) | 01-Dec-23 | Private Purchase | 220 | $3.35 | $737.00 | < 1% 2.44M to 2.44M | |
| 28-Nov-23 4:10 PM View: | Song Paul Y. Chief Executive Officer Director | Nkgen Biotech, Inc. (NKGN) | 27-Nov-23 | Private Purchase | 244 | $2.88 | $700.60 | < 1% 170.46K to 170.7K | |
| 22-Nov-23 5:53 PM View: | Song Paul Y. Chief Executive Officer Director | Nkgen Biotech, Inc. (NKGN) | 22-Nov-23 | Purchase | 53 | $2.85 | $149.99 | < 1% 170.41K to 170.46K | |
| 22-Nov-23 5:55 PM View: | Graf James A Interim CFO | Nkgen Biotech, Inc. (NKGN) | 21-Nov-23 | Purchase | 13 | $2.91 | $37.90 | < 1% 2.44M to 2.44M | |
| 22-Nov-23 5:53 PM View: | Song Paul Y. Chief Executive Officer Director | Nkgen Biotech, Inc. (NKGN) | 21-Nov-23 | Private Purchase | 100 | $2.80 | $280.00 | < 1% 170.31K to 170.41K | |
| 22-Nov-23 5:55 PM View: | Graf James A Interim CFO | Nkgen Biotech, Inc. (NKGN) | 20-Nov-23 | Private Purchase | 10 | $2.94 | $29.40 | < 1% 2.44M to 2.44M | |
| 04-Oct-23 6:10 AM View: | Graf Acquisition Partners I... 10% Owner | Nkgen Biotech, Inc. (NKGN) | 29-Sep-23 | Disposition (other) | 1,773,630 | -- | -- | (42%) 4.21M to 2.44M | |
| 14-Jul-21 4:54 PM View: | Graf Acquisition Partners I... Chief Executive Officer 10% Owner | Nkgen Biotech, Inc. (NKGN) | 14-Jul-21 | Disposition (other) | 20,000 | -- | -- | (< 1%) 4.23M to 4.21M | |
| 02-Jun-21 5:13 PM View: | Graf Acquisition Partners I... Chief Executive Officer 10% Owner | Nkgen Biotech, Inc. (NKGN) | 02-Jun-21 | Disposition (other) | 22,125 | -- | -- | (< 1%) 4.25M to 4.23M | |
| 03-Jun-21 6:03 AM View: | Graf James A Chief Executive Officer | Nkgen Biotech, Inc. (NKGN) | 01-Jun-21 | Market Purchase | 3,182 | $9.90 | $31,501.80 | < 1% 4.23M to 4.24M | (< 1%) |
| 03-Jun-21 6:03 AM View: | Graf James A Chief Executive Officer | Nkgen Biotech, Inc. (NKGN) | 28-May-21 | Market Purchase | 1,818 | $9.90 | $17,998.20 | < 1% 4.23M to 4.23M | (< 1%) |
| 27-May-21 4:57 PM View: | Graf James A Chief Executive Officer | Nkgen Biotech, Inc. (NKGN) | 27-May-21 | Market Purchase | 80 | $9.93 | $794.40 | < 1% 4.25M to 4.25M | (< 1%) |
| 27-May-21 4:57 PM View: | Graf James A Chief Executive Officer | Nkgen Biotech, Inc. (NKGN) | 26-May-21 | Market Purchase | 320 | $9.91 | $3,171.20 | < 1% 4.25M to 4.25M | (< 1%) |
| 26-May-21 9:05 PM View: | Garcia Gus Co-President Director | Nkgen Biotech, Inc. (NKGN) | 26-May-21 | Market Purchase | 900 | $9.92 | $8,928.00 | 150% 0.6K to 1.5K | (< 1%) |
| 26-May-21 9:05 PM View: | Garcia Gus Co-President Director | Nkgen Biotech, Inc. (NKGN) | 25-May-21 | Purchase | 600 | $9.93 | $5,958.00 | 100% 0 to 0.6K | |
| 25-May-21 7:45 PM View: | Graf James A Chief Executive Officer | Nkgen Biotech, Inc. (NKGN) | 25-May-21 | Purchase | 222 | $9.90 | $2,197.80 | < 1% 8.51M to 8.51M | |
| 27-May-21 4:57 PM View: | Graf James A Chief Executive Officer | Nkgen Biotech, Inc. (NKGN) | 25-May-21 | Purchase | 100 | $9.94 | $994.00 | < 1% 4.25M to 4.25M | |
| 25-May-21 7:45 PM View: | Graf James A Chief Executive Officer | Nkgen Biotech, Inc. (NKGN) | 24-May-21 | Purchase | 28 | $9.94 | $278.32 | < 1% 8.51M to 8.51M | |
| 25-May-21 7:45 PM View: | Graf James A Chief Executive Officer | Nkgen Biotech, Inc. (NKGN) | 21-May-21 | Purchase | 1,050 | $9.95 | $10,447.50 | < 1% 8.51M to 8.51M |
